| |||
 | |||
 |
Hawthorn | ||
| |||
| |||
| |||
|
Creatine | ||
| |||
|
| Pronunciation |
 (sye
kloe PEN toe late & fen il EF
rin) |
 |
| U.S. Brand Names |
| Cyclomydril® Ophthalmic |
|
| Generic Available |
|
No |
|
| Synonyms |
| Phenylephrine and Cyclopentolate |
|
| Pharmacological Index |
|
Ophthalmic Agent, Antiglaucoma |
|
| Use |
|
Induce mydriasis greater than that produced with cyclopentolate HCl alone |
|
| Pregnancy Risk Factor |
|
C |
|
| Stability |
|
Store in tight containers and protect from light |
|
| Usual Dosage |
|
Ophthalmic: Neonates, Infants, Children, and Adults: Instill 1 drop into the eye every 5-10 minutes, for up to 3 doses, approximately 40-50 minutes before the examination |
|
| Administration |
|
Finger pressure should be applied to lacrimal sac for 1-2 minutes after instillation to decrease risk of absorption and systemic reactions |
|
| Dental Health: Local Anesthetic/Vasoconstrictor Precautions |
|
No information available to require special precautions |
|
| Dental Health: Effects on Dental Treatment |
|
No effects or complications reported |
|
| Patient Information |
|
May cause blurred vision and increased sensitivity to light |
|
| Dosage Forms |
|
Solution, ophthalmic: Cyclopentolate hydrochloride 0.2% and phenylephrine hydrochloride 1% (2 mL, 5 mL) |
|
|
|
Copyright © 1978-2000 Lexi-Comp Inc. All Rights Reserved
